Tech Company Financing Transactions
CureMatch Funding Round
CureMatch closed a Series A funding round on 8/17/2017. Backers included private investors and Serra Ventures.
Transaction Overview
Company Name
Announced On
8/17/2017
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
private investors (Phil Trubey)
Serra Ventures (Steve Beck)
Proceeds Purpose
CureMatch is at a point of its growth where our partnership with Serra Ventures will help us to further accelerate the deployment of our personalized cancer treatment technology, said Blaise Barrelet, CEO of CureMatch. This will allow us to improve patient outcomes now instead of tomorrow.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
6440 Lusk Blvd. D206
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
CureMatch, Inc. is a San Diego-based digital health company focused on personalized medicine and combination therapy in oncology. CureMatch's Decision Support System guides oncologists in the selection of cancer drugs that are customized for individual patients based on their molecular tumor profile.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Blaise Barrelet
Chief Executive Officer
Robert Manning
Chief Medical Officer
Razelle Kurzrock
Chief Operating Officer
Stephane Richard
Chief Technical Officer
Igor Tsigelny
VP - Engineering
Philippe Faurie
VP - Operations
Gilles Godard
Browse more venture capital transactions:
Prev: 8/17/2017: GeoTix venture capital transaction
Next: 8/17/2017: Puls venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs